Lipocine Inc. — Director's Dealing 2014

Jan 8, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2014-01-06

Reporting Person: Fink Jeffrey Arvin (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-06	Stock Option (Right to Buy)	$8.25	A	10000	Acquired	2024-01-06	Common stock (10000)	Direct